Boehringer-Ingelheim and Lilly Alliance has provided funding towards this educational programme. The Alliance has had no editorial input or influence on the agenda, collateral content of this meeting including the selection of speakers.

The Cardiorenal Forum is pleased to be broadcasting this free, independent, online educational video for healthcare professionals as part of the activities for its 19th Annual Scientific Meeting.

Online educational video objectives

• To review recently published guidelines from KDIGO (Kidney Disease Improving Global Outcomes) for the Evaluation and Management of Chronic Kidney Disease (CKD).
• To consider that, despite multiple guidelines-based medical management, patients with CKD continue to experience residual cardiorenal risk.
• To look at the evidence for new drugs that have become available that could potentially transform CKD care and significantly improve clinical outcomes.
• To review the ‘known knowns and known unknowns’ of medical therapies proven to delay CKD progression.
• To assess whether we are moving towards acknowledged ‘Foundational drugs’ or ‘Pillars’ for early treatment of cardiorenal disease.

Is it for me?

This online educational video is aimed at healthcare professionals treating the cardiorenal patient particularly those working in heart failure, cardiology, nephrology, diabetes, lipids, endocrinology, care of the elderly, general medicine, general practice, clinical pharmacy and allied disciplines. It will be free to register and view.

Accreditation

The Cardiorenal Forum will award 1 CPD credit for viewing this online educational video.

Academic endorsement

The Cardiorenal Forum is in academic partnership with KDIGO (Kidney Disease Improving Global Outcomes).

This year’s 19th Annual Scientific meeting of the Cardiorenal Forum has been endorsed by: The British Society for Heart Failure, The Irish Nephrology Society, KDIGO – Kidney Disease Improving Global Outcomes, The UK Kidney Association, and The UK Renal Pharmacy Group.